-17%

est. 2Y upside i

HealthcareSeries C

Rank

#494

Sector

Master Data Management, Healthcare IT

Est. Liquidity

~3Y

Data Quality

Data: Medium

Verato presents a strong upside opportunity for a job seeker, with an estimated 116% expected upside over a two-year horizon.

Last updated: March 10, 2026

Bull (35%)+200%

Verato's proprietary Referential Matching technology gains significant traction, expanding market share rapidly in both healthcare and cross-industry identity resolution. Revenue reaches ~$72M by 2028 with an expanded 15x ARR multiple, leading to a $1.08B valuation, capped at +200% upside given Series C stage constraints.

Base (40%)+125%

Verato maintains its 50% YoY growth, solidifying its position in healthcare MDM and making inroads into other regulated industries. Revenue reaches ~$63M by 2028, sustaining a 10x ARR multiple for a $630M valuation.

Bear (25%)-15%

Increased competition from incumbents or well-funded startups, coupled with slower-than-expected market adoption, causes growth to decelerate to 20% YoY. Revenue reaches ~$40M by 2028, and multiple compresses to 6x ARR, resulting in a $240M valuation and a -15% downside for common shareholders.

Est. time to liquidity~2.5 years

Preference Stack Risk

moderate

Investors hold $35M in liquidation preferences. In an exit at the estimated current valuation of $280M, $245M would be available for common shareholders after preferences are paid (assuming 1x non-participating preferred).

Dilution Risk

moderate

The company has not raised an equity round since 2019; another funding round is likely before an exit, which would cause further dilution for existing equity holders.

Secondary Liquidity

none

There is no public information indicating active secondary markets or tender offers for Verato's shares.

Questions to Ask at the Interview

Strategic questions based on Verato's data — designed to show you've done your homework.

  • 1

    “Given Verato's strong competitive moat with Referential Matching, how is the company strategically thinking about defending its market position against potential enhanced identity resolution offerings from large incumbents like Oracle Health or Informatica?”

  • 2

    “With significant growth in the healthcare MDM segment, what are the key milestones and challenges Verato anticipates in expanding its identity resolution capabilities more aggressively into the broader cross-industry market, and how will this impact the revenue mix?”

  • 3

    “Considering the last funding round was in 2019, what is the company's current perspective on the timeline for a liquidity event, such as an IPO or acquisition, and how does this outlook inform the strategy for employee equity and future dilution?”

Community

Valuation Sentiment

Our model estimates -17% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.